Zacks Investment ResearchThu, 07 May 2026 20:16:05 GMTLipocine (LPCN) Reports Q1 Loss, Beats Revenue EstimatesLPCN-0.84%
BenzingaThu, 02 Apr 2026 14:58:03 GMTLipocine Stock Plunges After LPCN 1154 Misses Phase 3 Primary EndpointLPCN-0.84%
Zacks Investment ResearchFri, 27 Feb 2026 13:47:08 GMTLipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?LPCN-0.84%